Capitolis Advisors’s Teladoc Health TDOC Stock Holding History

Capitolis Advisors’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-45,618	Closed	-$4.19M	–	457
2021 Q4	$4.19M	Buy	+45,618	New	+$5.45M	0.03%	331

Other funds holding TDOC

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Capitolis Advisors's TDOC Position: Q1 2022 in Review

Capitolis Advisors sold out of Teladoc Health (TDOC) in Q1 2022, closing a stake of 45,618 shares — an estimated $4.19M sold.

Capitolis Advisors first reported a position in TDOC in Q4 2021 and held it in 1 quarter. The position peaked at $4.19M in Q4 2021. 679 funds tracked by Wall St. Rank hold TDOC as of Q1 2022.

Capitolis Advisors reported no remaining Teladoc Health position as of Q1 2022 after selling out during the quarter.
Capitolis Advisors sold 45,618 Teladoc Health shares in Q1 2022, an estimated $4.19M.
Capitolis Advisors first reported a position in Teladoc Health in Q4 2021 and held it in 1 quarter.
Capitolis Advisors's Teladoc Health position peaked at $4.19M in Q4 2021.
679 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2022.

Based on Capitolis Advisors's 13F filing for Q1 2022, filed 12 May 2022.